Daniela Sartori

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Daniela Sartori is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

3 Article

Docetaxel and prednisone with or without enzalutamide as first-line treatment in patients with metastatic castration-resistant prostate cancer: CHEIRON, a randomised phase II trial
Caffo, O., Ortega, C., Nolè, F., Gasparro, D., Mucciarini, C., Aieta, M., Zagonel, V., Iacovelli, R., De Giorgi, U., Facchini, G., Veccia, A., Palesandro, E., Verri, E., Buti, S., Razzini, G., Bozza, G., Maruzzo, M., Ciccarese, C., Schepisi, G., Rossetti, S., & 20 othersMaines, F., Fratino, L., Ermacora, P., Nicodemo, M., Giordano, M., Sartori, D., Scapoli, D., Sabbatini, R., Lo Re, G., Morelli, F., D'Angelo, A., Vittimberga, I., Lippe, P., Carrozza, F., Messina, C., Galli, L., Valcamonico, F., Porta, C., Pappagallo, G. & Aglietta, M., 2021, In: European Journal of Cancer. 155, p. 56-63 8 p.
Research output: Contribution to journal › Article › peer-review
Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG
Bersanelli, M., Giannarelli, D., De Giorgi, U., Pignata, S., Di Maio, M., Verzoni, E., Clemente, A., Guadalupi, V., Signorelli, D., Tiseo, M., Giusti, R., Filetti, M., Di Napoli, M., Calvetti, L., Cappetta, A., Ermacora, P., Zara, D., Barbieri, F., Baldessari, C., Scotti, V., & 53 othersMazzoni, F., Veccia, A., Guglielmini, P. F., Maruzzo, M., Rossi, E., Grossi, F., Casadei, C., Cortellini, A., Verderame, F., Montesarchio, V., Rizzo, M., Mencoboni, M., Zustovich, F., Fratino, L., Cinieri, S., Negrini, G., Banzi, M., Sorarù, M., Zucali, P. A., Lacidogna, G., Russo, A., Battelli, N., Fornarini, G., Mucciarini, C., Bracarda, S., Bonetti, A., Pezzuolo, D., Longo, L., Sartori, D., Iannopollo, M., Cavanna, L., Meriggi, F., Tassinari, D., Corbo, C., Gernone, A., Prati, V., Carnio, S., Giordano, P., Dicorato, A. M., Verusio, C., Atzori, F., Carrozza, F., Gori, S., Castro, A., Pilotto, S., Vaccaro, V., Garzoli, E., Di Costanzo, F., Maiello, E., Labianca, R., Pinto, C., Tognetto, M. & Buti, S., 2020, In: Therapeutic Advances in Medical Oncology. 12, 1758835920968463.
Research output: Contribution to journal › Article › peer-review
A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study
Gagno, S., D'Andrea, M. R., Mansutti, M., Zanusso, C., Puglisi, F., Dreussi, E., Montico, M., Biason, P., Cecchin, E., Iacono, D., Russo, S., Cinausero, M., Saracchini, S., Gasparini, G., Sartori, D., Bari, M., Collovà, E., Meo, R., Merkabaoui, G., Spagnoletti, I., & 20 othersPellegrino, A., Gianni, L., Sandri, P., Cretella, E., Vattemi, E., Rocca, A., Serra, P., Fabbri, M. A., Benedetti, G., Foghini, L., Medici, M., Basso, U., Amoroso, V., Riccardi, F., Baldelli, A. M., Clerico, M., Bonura, S., Saggia, C., Innocenti, F. & Toffoli, G., 2018, In: Clinical Breast Cancer.
Research output: Contribution to journal › Article › peer-review

Daniela Sartori

Fingerprint

Research output

Docetaxel and prednisone with or without enzalutamide as first-line treatment in patients with metastatic castration-resistant prostate cancer: CHEIRON, a randomised phase II trial

Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG

A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study